SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-002855
Filing Date
2021-01-08
Accepted
2021-01-08 21:49:03
Documents
1
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 5190
  Complete submission text file 0001209191-21-002855.txt   6647
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (206) 221-8112
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O DORMAN PRODUCTS, INC. 3400 EAST WALNUT STREET COLMAR PA 18915
Business Address
Romano Kelly A (Reporting) CIK: 0001722055 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-39503 | Film No.: 21518931